Basecamp Research Launches Trillion Gene Atlas to Scale AI-Designed Therapeutics

Basecamp Research Texas California

The Atlas will expand known evolutionary genetic diversity by 100x, collecting novel genomic data from over 100 million new species across thousands of sites globally.By partnering with Anthropic, Ultima Genomics, and PacBio, and powered by NVIDIA AI infrastructure, Basecamp Research aims to compress over two decades of biological data gathering and analysis into less than two years.Training the EDEN models revealed new scaling laws: as biological datasets grow larger and richer, AI capabilities jump - opening the door to systems that can design new medicines across diseases and treatment types.to significantly accelerate metagenomic assembly. This collaboration focuses on both advanced engineering and the development of new algorithmic methods to optimize how complex environmental samples are reconstructed. Thanks to this acceleration, processing quadrillions of DNA base pairs, a task that would have previously taken over 20 years, is expected to take less than two years to complete.

Through parallelized data processing, automated annotation, and large-scale model training, the partners expect to compress a task that previously would have required more than 20 years of processing time to less than two years. This compression of sequencing, assembly, annotation and model training is intended to expand the performance and scope of biological foundation models across therapeutic development.

Creating an Agentic End-to-End Therapeutic Design Workflow

Anthropic joins as part of its broader effort to add new capabilities for life sciences: connecting Claude to more scientific platforms. Working with the Claude for Life Sciences team, the aim is to harness the Trillion Gene Atlas and EDEN to make Claude an even more productive research partner for scientists and clinicians, and support organisations bringing new scientific advancements to the public.

By combining Claude's advanced reasoning capabilities, EDEN's therapeutic design capabilities, and NVIDIA's CUDA-X Libraries to process unstructured data, the initiative aims to create an integrated workflow for interpreting complex clinical data and translating it directly into therapeutic design.

The Trillion Gene Atlas is built on three pillars: large-scale DNA sequencing, global data supply partnerships and advanced computing. Together with AI systems capable of reasoning across complex data, these foundations can help turn vast datasets into therapeutic discoveries. By increasing the evolutionary data available to AI by another 100x, Basecamp Research aims to make drug design faster and more systematic - extending EDEN's earlier advances in fields like gene therapy and the fight against antibiotic-resistant bacteria.

View original content:https://www.prnewswire.co.uk/news-releases/basecamp-research-launches-trillion-gene-atlas-to-scale-ai-designed-therapeutics-302716632.html